Women harboring germline pathogenic variants (PV) in the breast cancer Type 1 susceptibility gene (BRCA1) have a lifetime risk of breast and high-grade serous ovarian cancer (HGSOC) exceeding 70% and 40%, respectively [1]. This evidence concerns the gene BRCA1 and ovarian serous adenocarcinoma.